委外研發機構的市場規模、佔有率、成長分析，按應用、按最終用戶、按地區 - 行業預測，2024-2031

2022年全球合約藥物委外研發機構市場規模約為680億美元，高於2023年的751億美元，在預測期間（2024-2031）至2031年的複合年成長率為9.5%，預計將達到1552億美元。

由於臨床試驗的複雜性不斷增加以及對外包研究服務的需求不斷增加，全球合約委外研發機構（CRO）市場正在穩步成長。 CRO 提供廣泛的服務，包括臨床試驗管理、資料管理、法規事務和化驗服務。 CRO 協助製藥、生技和醫療設備公司簡化研發流程、降低成本並加快新產品的上市時間。市場高度分散，參與者眾多，從大型全方位服務 CRO 到小型利基公司。技術進步，特別是資料分析和數位健康解決方案，正在對市場動態產生重大影響。對個人化醫療的日益重視和慢性病的盛行率增加也促進了市場的擴張。此外，主要市場參與者之間的策略聯盟和併購正在塑造競爭格​​局。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 次要/一級資訊來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及前景

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 市場生態系統
• 價值鏈分析
• 價格分析
• 案例研究分析
• 技術分析
• 監管分析
• 創新矩陣
• 重點投資分析
• 關鍵成功因素
• 競爭程度

藥品委外研發機構市場：按類型

• 市場概況
• 臨床研究服務
  • 按階段
  • 第三階段
  • 第二階段
  • 第一階段
  • 第四階段
  • 依研究設計（III期/IV期）
  • 干涉
  • 真實世界證據 (RWE)
• 初期開發服務
  • 化學、製造和控制服務
  • 臨床前服務
  • 藥物動力學/動態服務
  • 毒理學測試服務
  • 其他臨床前服務
  • 發現研究
• 化驗服務
  • 分析測試服務
  • 物理表徵服務
  • 原料檢測服務
  • 大量發布測試服務
  • 穩定性測試服務
  • 其他分析測試服務
  • 生物分析測試服務
• 諮詢服務
• 資料管理服務

藥物委外研發機構市場：依治療領域

• 市場概況
• 腫瘤學
  • 乳癌
  • 肺癌
  • 大腸直腸癌
  • 攝護腺癌
  • 其他癌症
• 感染疾病
• CVS 故障
• 神經病學
• 疫苗
• 代謝疾病/內分泌學
• 免疫疾病
• 精神病學
• 呼吸系統疾病
• 皮膚科
• 眼科
• 消化系統疾病
• 泌尿系統和女性健康
• 血液學
• 其他治療領域

藥品委外研發機構市場：依最終用戶分類

• 市場概況
• 製藥和生物製藥公司
• 醫療設備公司
• 學術機構

藥品委外研發機構市場規模：按地區分類

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要參與者採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• IQVIA
• Laboratory Corporation of America Holdings（Labcorp）
• PPD Inc.（a part of Thermo Fisher Scientific, Inc.）
• Syneos Health Inc.
• WuXi AppTec Co., Ltd.
• Charles River Laboratories International, Inc.
• Parexel International Corporation
• Pharmaron Beijing Co., Ltd.
• ICON PLC
• Medpace Holdings, Inc.
• SGS SA
• Frontage Holdings Corporation
• PSI CRO AG
• BioAgile Therapeutics Pvt. Ltd.
• Firma Clinical Research, LLC
• AccuLab Life Sciences
• Novotech Health Holdings
• KCR（formerly Kiecana Clinical Research）
• Linical Co., Ltd.
• Advanced Clinical
• Azelix LLC
• Clinical Trial Service BV
• Pepgra Healthcare Pvt. Ltd.
• Worldwide Clinical Trials Holdings Inc.
• CTI Clinical Trial and Consulting Services, Inc

Global Contract Research Organization Market size was valued at around 68 billion in 2022 and is expected to rise from USD 75.1 billion in 2023 to reach a value of USD 155.2 billion by 2031, at a CAGR of 9.5% over the forecast period (2024-2031).

The global Contract Research Organization (CRO) market has experienced robust growth due to the increasing complexity of clinical trials and the rising demand for outsourced research services. CROs provide a range of services including clinical trial management, data management, regulatory affairs, and laboratory services. They are instrumental in helping pharmaceutical, biotechnology, and medical device companies streamline their R&D processes, reduce costs, and accelerate time-to-market for new products. The market is characterized by a high degree of fragmentation, with numerous players ranging from large, full-service CROs to smaller niche firms. Technological advancements, particularly in data analytics and digital health solutions, are significantly impacting the market dynamics. The growing emphasis on personalized medicine and the increasing prevalence of chronic diseases are also contributing to the market's expansion. Additionally, strategic collaborations and mergers and acquisitions among key market players are shaping the competitive landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Contract Research Organization Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Contract Research Organization Market Segmental Analysis

Global Contract Research Organization Market is segmented by Type, Therapeutic Area, End User, and region. Based on Product, the market is segmented into Clinical Research Services ( Phase (Phase III, Phase II, Phase I, Phase IV), By Study Design (For Phase III & IV) (Interventional, Real World Evidence (RWE)), Early phase development Services (Chemistry, Manufacturing and Controls Services, Preclinical Services (Pharmacokinetics/ Pharmacodynamics Services, Toxicology Testing Services, Other Preclinical Services), Discovery Studies), Laboratory Services (Analytical Testing Services (Physical Characterization Services, Raw Material Testing Services, Batch Release Testing Services, Stability Testing Services, Other Analytical Testing Services), Bioanalytical Testing Services), Consulting Services, and Data Management Services. Based on Therapeutic Area, the market is segmented into Oncology (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Other Cancer), Infectious Diseases, CVS Disorders, Neurology, Vaccines, Metabolic Disorders/Endocrinology, Immunological Disorders, Psychiatry, Respiratory Disorders, Dermatology, Ophthalmology, Gastrointestinal Diseases, Genitourinary & Women's Health, Hematology, and Other Therapeutic Areas. Based on End User, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, and Academic Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Contract Research Organization Market

One major driver of the global CRO market is the rising need for cost-effective and efficient R&D solutions. Pharmaceutical and biotechnology companies are increasingly outsourcing clinical trials and other research activities to CROs to manage costs and mitigate risks associated with drug development. CROs offer specialized expertise and resources that can help streamline the drug development process, reduce operational costs, and improve the overall efficiency of clinical trials. This trend is particularly prevalent among smaller companies and startups that lack the extensive infrastructure required for large-scale clinical research. By leveraging CROs, these organizations can focus on their core competencies while benefiting from the CROs' experience, advanced technologies, and global reach, which ultimately supports faster and more cost-effective product development.

Restraints in the Global Contract Research Organization Market

A significant restraint in the global CRO market is the regulatory complexity and variability across different regions. CROs must navigate diverse regulatory requirements and standards set by various health authorities worldwide, which can be challenging and time-consuming. The differences in regulations, clinical trial procedures, and data privacy laws between countries can lead to delays, increased costs, and potential compliance issues. This regulatory burden can affect the efficiency of clinical trials and pose challenges for CROs in managing multi-regional studies. Additionally, discrepancies in regulatory guidelines can impact the standardization of trial protocols and data reporting, complicating the process for both CROs and their clients.

Market Trends of the Global Contract Research Organization Market

A prominent trend in the global CRO market is the growing integration of advanced technologies, such as artificial intelligence (AI) and machine learning, into clinical trials. These technologies are revolutionizing the way clinical research is conducted by enhancing data analysis, improving patient recruitment, and optimizing trial designs. AI algorithms can analyze vast amounts of data to identify potential drug candidates, predict patient responses, and uncover new insights that can accelerate the drug development process. Additionally, machine learning tools are being used to streamline data management and enhance decision-making processes. This technological advancement is helping CROs deliver more accurate and efficient research outcomes, thereby increasing their value proposition to pharmaceutical and biotechnology companies. The adoption of these technologies is expected to continue growing, further driving innovation and efficiency in the CRO market.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Ecosystem of the Market
• Value Chain Analysis
• Pricing Analysis
• Case Study Analysis
• Technology Analysis
• Regulatory Analysis
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Contract Research Organization Market by Type

• Market Overview
• Clinical Research Services
  • By Phase
  • Phase III
  • Phase II
  • Phase I
  • Phase IV
  • By Study Design (For Phase III & IV)
  • Interventional
  • Real World Evidence (RWE)
• Early phase development Services
  • Chemistry, Manufacturing and Controls Services
  • Preclinical Services
  • Pharmacokinetics/ Pharmacodynamics Services
  • Toxicology Testing Services
  • Other Preclinical Services
  • Discovery Studies
• Laboratory Services
  • Analytical Testing Services
  • Physical Characterization Services
  • Raw Material Testing Services
  • Batch Release Testing Services
  • Stability Testing Services
  • Other Analytical Testing Services
  • Bioanalytical Testing Services
• Consulting Services
• Data Management Services

Contract Research Organization Market by Therapeutic Area

• Market Overview
• Oncology
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Other Cancer
• Infectious Diseases
• CVS Disorders
• Neurology
• Vaccines
• Metabolic Disorders/Endocrinology
• Immunological Disorders
• Psychiatry
• Respiratory Disorders
• Dermatology
• Ophthalmology
• Gastrointestinal Diseases
• Genitourinary & Women's Health
• Hematology
• Other Therapeutic Areas

Contract Research Organization Market by End User

• Market Overview
• Pharmaceutical & Biopharmaceutical Companies
• Medical Device Companies
• Academic Institutes

Contract Research Organization Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• IQVIA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratory Corporation of America Holdings (Labcorp)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PPD Inc. (a part of Thermo Fisher Scientific, Inc.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syneos Health Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parexel International Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharmaron Beijing Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medpace Holdings, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGS SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Frontage Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PSI CRO AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioAgile Therapeutics Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Firma Clinical Research, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AccuLab Life Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novotech Health Holdings
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KCR (formerly Kiecana Clinical Research)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Linical Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Clinical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Azelix LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clinical Trial Service BV
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pepgra Healthcare Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Worldwide Clinical Trials Holdings Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CTI Clinical Trial and Consulting Services, Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments